J&J Will Have Up to 800 Million COVID-19 Vaccines Available by Early 2021: CFO

J&J Will Have Up to 800 Million COVID-19 Vaccines Available by Early 2021: CFO
A researcher works at a Johnson & Johnson research facility, in Val-de-Reuil, northwestern France, on Nov. 30, 2017. Charly Triballeau/AFP via Getty Images
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

Johnson & Johnson expects to have up to 800 million vaccines available by early next year for the COVID-19 disease, one of the strongest projections from a company involved in researching the vaccines.

No vaccines currently exist for COVID-19, which is caused by the CCP (Chinese Communist Party) virus, a new coronavirus that emerged from mainland China last year. There are no proven treatments either, though some have shown promise.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics